Degeneracy: Demystifying and destigmatizing a core concept in systems biology

Complexity

Volumn 20, Issue 3, 2015, Pages 12-21

  Mason, Paul H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Complexity; Degeneracy; Degeneration; Evolvability; Robustness; Selection; Systems biology

Indexed keywords

EID: 84920991728     PISSN: 10762787     EISSN: 10990526     Source Type: Journal    
DOI: 10.1002/cplx.21534     Document Type: Note

References (172)

1. Atamas, S.P. Les affinités sélectives. Pour la Sci 2005, 46, 39-43.
2. Boyd-Bowman, P. Lexico Hispanoamericano Del Siglo XVI; Tamesis: London, 1971.
3. Palmié, S. The "C-Word" again: From colonial to postcolonial semantics. In: Creolization: History, Ethnography, Theory; Stewart, C., Ed.; Left Coast Press: Walnut Creek, CA, 2007; pp 66-83.
4. Commerçon, P. [Letter to Joseph Lalande], Mercure de France, November, 1769.
5. Greenslade, W. Degeneration, Culture and the Novel; Cambridge University Press: Cambridge, 1994.
6. Pick, D. Faces of Degeneration: A European Disorder, c. 1848-1918; Cambridge University Press: Cambridge, 1989.
7. Mason, P.H. Degeneracy at multiple levels of complexity. Biol Theory 2010, 5, 277-288.
8. Grignolio, A.; Tieri, P.; Castellani, G. Networks, degeneracy and bow ties: A unifying perspective of immunological paradigms and architectures. In: Immunology Today: Three Historical Perspectives under Three Theoretical Horizons; Grignolio, A., Ed.; Bologna University Press: Bologna, 2010; pp 53-68.
9. Crick, F.H.C. On Degenerate Templates and the Adaptor Hypothesis; Medical Research Council Unit for the Study of the Molecular Structure of Biological Systems Cavendish Laboratory: Cambridge, England, 1955.
10. Harper, E. In appreciation, George Gamow: Scientific amateur and polymath. Phys Perspect 2001, 3, 335-372.
11. Woese, C.R. Translation: In retrospect and prospect. RNA 2001, 7, 1055-1067.
12. Behura, S.K.; Severson, D.W.; Codon usage bias: Causative factors, quantification methods and genome-wide patterns: With emphasis on insect genomes. Biol Rev 2013, 88, 49-61.
13. Brown, B.R. Until Darwin, Science, Human Variety and the Origins of Race; Pickering & Chatto: London, UK, 2010.
14. Lawrence, C. Degeneration under the microscope at the fin se siècle. Ann Sci 2009, 66, 1-17.
15. Lawrence, C. Historical keyword: Degeneration. Lancet 2010, 375, 975.
16. Calne, D.B. Neurodegenerative Disease; Saunders: Philadelphia, 1994.
17. Bermejo-Pareja, F. An old problem not yet resolved: The association of several neurodegenerative disorders. Neuroepidemiology 2011, 37, 11-12.
18. Pryse-Phillips, W. Companion to Clinical Neurology. Little Brown: Boston, 1995.
19. Somogyi, R.; Sniegoski, C.A. Modeling the complexity of genetic networks: Understanding multigenic and pleiotropic regulation. Complexity 1996, 1, 45-63.
20. News items. Complexity 2009, 15, 3-9.
21. Gershenson, C. News items. Complexity 2010, 15, 3-9.
22. Gershenson, C. News items. Complexity 2011, 16, 1-6.
23. Bertolaso, M.; Giuliani, A.; De Gara, L. Systems biology reveals biology of systems. Complexity 2011, 16, 10-16.
24. Tononi, G.; Sporns, O.; Edelman, G.M. Measures of degeneracy and redundancy in biological networks. Proc Natl Acad Sci USA 1999, 96, 3257-3262.
25. Ritz, N.; Milton, M.; Balloch, A.; Curtis, N. Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations. Vaccine 2013, 31, 3098-3103.
26. Shann, F. The non-specific effects of vaccines. Arch Dis Child 2010, 95, 662-667.
27. Tieri, P.; Grignolio, A.; Zaikin, A.; Mishto, M.; Remondini, D.; Castellani, G.C.; Franceschi, C. Network, degeneracy and bow tie: Integrating paradigms and architectures to grasp the complexity of the immune system. Theor Biol Med Model 2010, 7, 32.
28. Goodman, H.M.; Rich, A. Formation of a DNA-soluble RNA hybrid and its relation to the origin, evolution, and degeneracy of soluble RNA. Proc Natl Acad Sci USA 1962, 48, 2101-2109.
29. Reichmann, M.; Markham, R.; Symons, R.; Rees, M. Experimental evidence for degeneracy of nucleotide triplet code. Nature 1962, 195, 999-1000.
30. Weisblum, B.; Benzer, S.; Holley, R.W. A physical basis for degeneracy in the amino acid code. Proc Natl Acad Sci USA 1962, 48, 1449-1454.
31. Barnett, W.E.; Jacobson, K.B. Evidence for degeneracy and ambiguity in interspecies aminoacyl-sRNA formation. Proc Natl Acad Sci USA 1964, 51, 642-647.
32. Weisblum, B.; Gonano, F.; Von Ehrenstein, G.; Benzer, S. A demonstration of coding degeneracy for leucine in the synthesis of protein. Proc Natl Acad Sci USA 1965, 53, 328-334.
33. Mitchell, W.M. A model for protein biosynthesis predicated on the concept of metastable states: A postulated role for genetic code degeneracy. Proc Natl Acad Sci USA 1968, 61, 742-747.
34. Konopka, A.K. Theory of degenerate coding and informational parameters of protein coding genes. Biochimie 1985, 67, 455-468.
35. Kurland, C.G. Evolution of mitochondrial genomes and the genetic code. BioEssays 1992, 14, 709-714.
36. Gu, Z.; Steinmetz, L.M.; Gu, X.; Scharfe, C.; Davis, R.W.; Li, W.H. Role of duplicate genes in genetic robustness against null mutations. Nature 2003, 421, 63-66.
37. Frank, S.A. Genetic variation of polygenic characters and the evolution of genetic degeneracy. J Evol Biol 2003, 16, 138-142.
38. Sequeira-Mendes, J.; Gómez, M. On the opportunistic nature of transcription and replication initiation in the metazoan genome. Bioessays 2012, 34, 119-125.
39. Subramaniam, A.R.; Pan, T.; Cluzel, P. Environmental perturbations lift the degeneracy of the genetic code to regulate protein levels in bacteria. Proc Natl Acad Sci USA 2013, 110, 2419-2424.
40. Maleszka, R.; Mason, P.H.; Barron, A. Epigenomics and the concept of degeneracy in biological systems. Brief Funct Genomics 2013. Doi:10.1093/bfgp/elt050.
41. Gras-Masse, H.; Boutillon, C.; Diesis, E.; Deprez, B.; Tartar, A. Confronting the degeneracy of convergent combinatorial immunogens, or 'mixotopes', with the specificity of recognition of the target sequences. Vaccine 1997, 15, 1568-1578.
42. Bongrand, P.; Malissen, B. Quantitative aspects of T-cell recognition: From within the antigen-presenting cell to within the T cell. BioEssays 1998, 20, 412-422.
43. Wilson, D.B.; Wilson, D.H.; Schroder, K.; Pinilla, C.; Blondelle, S.; Houghten, R.A.; Garcia, K.C. Specificity and degeneracy of T cells. Mol Immunol 2004, 40, 1047-1055.
44. Cohen, I.R.; Hershberg, U.; Solomon, C. Antigen-receptor degeneracy and immunological paradigms. Mol Immunol 2004, 40, 993-996.
45. Calis, J.J.A.; de Boer, R.J.; Kesmir, C. Degenerate T-Cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire. PLoS Comput Biol 2012, 8, e1002412.
46. Doherty, D.G.; Penzotti, J.E.; Koelle, D.M.; Kwok, W.W.; Lybrand, T.P.; Masewicz, S.; Nepom, G.T. Structural basis of specificity and degeneracy of T cell recognition: Pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. J Immunol 1998, 161, 3527-3535.
47. Sette, A.J.; Sidney, C.; Oseroff, M.-F.; del Guercio, S.; Southwood, S.; Arrhenius, T.; Powell, M.F.; Colón, S.M.; Gaeta, F.C.; Grey, H.M. HLA- DR4Dw4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J Immunol 1993, 151, 3163.
48. Carmichael, P.; Copier, J.; So, A.; Lechler, R. Allele-specific variation in the degeneracy of major histocompatibility complex (MHC) restriction. Human Immunol 1997, 54, 21.
49. Mellen, N.M. Degeneracy as a substrate for respiratory regulation. Respir Physiol Neurobiol 2010, 172, 1-7.
50. Mayer-Kress, G.; Yeou-Teh, L.; Newell, K.M. Complex systems and human movement. Complexity 2006, 12, 40-41.
51. Barris, S.; Farrow, D.; Davids, K. Do the kinematics of a baulked take-off in springboard diving differ from those of a completed dive. J Sports Sci 2013, 31, 1-9.
52. Seifert, L.; Button, C.; Davids, K. Key properties of expert movement systems in sport. Sports Med 2013, 43, 167-178.
53. Komar, J.; Chollet, D.; Seifert, L. How the level of environmental constraint supports neurobiological degeneracy. In: Studies in Perception and Action XII; Davis, T. J.; Passos, P.; Dicks, M.; Weast-Knapp, J. A., Eds.; Psychology Press: Estoril, Portugal, 2013; pp 14-17.
54. Seifert, L.; Wattebled, L.; Herault, R.; Poizat, G.; Adé, D.; Gal-Petitfaux, N.; Davids, K. Neurobiological degeneracy and affordance perception support functional intra-individual variability of inter-limb coordination during ice climbing. PLOS ONE 2014, 9, e89865.
55. Seifert, L.; Davids, K. Intentions, perceptions and actions constrain functional intra-and inter-individual variability in the acquisition of expertise in individual sports. Open Sports Sci J 2012, 5, 68-75.
56. Price, C.J.; Friston, K.J. Degeneracy and cognitive anatomy. Trends Cogn Sci 2002, 6, 416-421.
57. Friston, K.; Price, C.J. Degeneracy and redundancy in cognitive anatomy. Trends Cogn Sci 2003, 7, 151-152.
58. Noppeney, U.; Friston, K.J.; Price, C.J. Degenerate neuronal systems sustaining cognitive functions. J Anat 2004, 205, 433-442.
59. Levine, B. Brain imaging and neuropsychology: Scope, limitations, and implications for degeneracy in neural systems. Neuropsychol Rehabil 2004, 14, 473-476.
60. Leonardo, A. Degenerate coding in neural systems. J Comp Physiol A: Neuroethol Sens Neural Behav Physiol 2005, 191, 995-1010.
61. Edelman, G.M. Synthetic neural modeling and brain-based devices. Biol Theory: Integr Dev Evol Cogn 2006, 1, 8-9.
62. Mitchell, K.J. The genetics of brain wiring: From molecule to mind. PLoS Biol 2007, 5, e113.
63. Figdor, C. Neuroscience and the multiple realization of cognitive functions. Philo Sci 2010, 77, 419-456.
64. Kelso, J.A.S. Multistability and metastability: Understanding dynamic coordination in the brain. Philos Trans R Soc B 2012, 367, 906-918.
65. Lewis, P.A.; Meck, W.H. Time and the sleeping brain. Psychologist 2012, 25, 594-97.
66. Merchant, H.; Harrington, D.L.; Meck, W.H. Neural basis of the perception and estimation of time. Ann Rev Neurosci 2013, 36, 313-336.
67. Edelman, G.M.; Gally, J.A. Degeneracy and complexity in biological systems. Proc Natl Acad Sci USA 2001, 98, 13763-13768.
68. McClellan, D.A. The codon-degeneracy model of molecular evolution. J Mol Evol 2000, 50, 131-140.
69. Tian, T.; Olson, S.; Whitacre, J.M.; Harding, A. The origins of cancer robustness and evolvability. Integr Biol 2011, 3, 17-30.
70. Deacon, T.W. A role for relaxed selection in the evolution of the language capacity. Proc Natl Acad Sci USA 2010, 107, 9000-9006.
71. Atamas, N.; Atamas, M.S.; Atamas, F.; Atamas, S.P. Non-local competition drives both rapid divergence and prolonged stasis in a model of speciation in populations with degenerate resource consumption. Theor Biol Med Model 2012, 9, 56.
72. Whitacre, J.; Atamas, S.P. Degeneracy allows for both apparent homogeneity and diversification in populations. Biosystems 2012, 110, 34-42.
73. Giovanni, B. Exaptation and emerging degeneracy in innovation processes. Econ Innov New Technol 2013, 22, 1-21.
74. Solé, R.V.; Ferrer-Cancho, R.; Montoya, J.M.; Valverde, S. Selection, tinkering, and emergence in complex networks. Complexity 2002, 8, 20-33.
75. Park, H.; Friston, K. Structural and functional brain networks: From connections to cognition. Science 2013, 342, 579.
76. Whitacre, J. Degeneracy: A link between evolvability, robustness complexity in biological systems. Theor Biol Med Model 2010, 7, 6.
77. Whitacre, J.; Bender, A. Degeneracy: A design principle for achieving robustness and evolvability. J Theor Biol 2010, 263, 143-153.
78. Meyers, L.A.; Ancel, F.D.; Lachmann, M. Evolution of genetic potential. PLoS Comput Biol 2005, 1, e32.
79. Joshi, N.J.; Tononi, G.; Koch, C. The minimal complexity of adapting agents increases with fitness. PLoS Comput Biol 2013, 9, e1003111.
80. Csermely, P. Strong links are important, but weak links stabilize them. Trends Biochem Sci 2004, 29, 331-334.
81. Atamas, S.P.; Bell, J. Degeneracy-driven self-structuring dynamics in selective repertoires. Bull Math Biol 2009, 71, 1349-1365.
82. Douglas, A.E.; Dobson, A.D. Animal communication mediated by microbes: Fact or fantasy? J Chem Ecol 2013, 39, 1149.
83. Russell, C.W.; Bougaine, S.; Newell, P.D.; Douglas, A.E. Shared metabolic pathways in a coevolved insect-bacterial symbiosis. App Environ Microbiol 2013, 79, 6117.
84. Force, A.; Lynch, M.; Pickett, F.B.; Amores, A.; Yan, Y.; Postlethwait, J. Preservation of duplicate genes by complementary, degenerative mutations. Genetics 1999, 151, 1531-1545.
85. Brookfield, J.F.Y. Genetic redundancy: Screening for selection in yeast. Curr Biol 1997, 7, R366-R368.
86. Dall, S.R.; Cuthill, I.C. Mutation rates: Does complexity matter? J Theor Biol 1999, 198, 283-285.
87. Nowak, M.A.; Boerlijst, M.C.; Cooke, J.; Maynard-Smith, J. Evolution of genetic redundancy. Nature 1997, 388, 167-171.
88. Bozorgmehr, J.E.H. Is gene duplication a viable explanation for the origination of biological information and complexity? Complexity 2011, 16, 17-31.
89. Budd, G.E. Why are arthropods segmented? Evol Dev 2001, 3, 132-142.
90. Budd, G.E. On the origin and evolution of major morphological characters. Biol Rev 2006, 81, 609-628.
91. Budd, G.E. Does evolution in body patterning genes drive morphological change-Or vice versa? BioEssays 1999, 21, 326-332.
92. Downey, G. Cultural variation in rugby skills: A preliminary neuroanthropological report. Ann Anthropol Pract 2010, 36, 26-44.
93. Davids, K.; Brymer, E.; Seifert, L.; Orth, D. A constraints-based approach to the acquisition of expertise in outdoor adventure sports. In: Complex Systems in Sport; Davids, K.; Hristovski, R.; Araújo, D.; Serre, N. B.; Button, C.; Passos, P. Eds.; Routledge: Oxon and London, 2013; pp 306-318.
94. Barris, S.; Farrow, D.; Davids, K. Increasing functional variability in the preparatory phase of the takeoff improves elite springboard diving performance. Res Q Exerc Sport 2014, 85, 97-106.
95. Davids, K.; Araujo, D.; Vilar, L.; Renshaw, I.; Pinder, R. An ecological dynamics approach to skill acquisition: Implications for development of talent in sport. Talent Dev Excell 2013, 5, 21-34.
96. Wenzel, S.E.; Schwarts, L.B.; Langmack, E.L. ; Halliday, J.L.; Trudeau, J.B.; Gibbs, R.L.; Chu, H.W. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999, 160, 1001-1008.
97. Wenzel, S.E. Asthma phenotypes: The evolution from clinical to molecular approaches. Nat Med 2012, 18, 716-725.
98. Kojovic . M.; Pareés, I.; Kassavetis, P.; Palomar, F.J.; et al. Secondary and primary dystonia: Pathophysiological differences. Brain 2013, 136, 2038-2049.
99. Steinhausen, H.C. The heterogeneity of causes and courses of attention-deficit/hyperactivity disorder. Acta Psychiatr Scand 2009, 120, 392-399.
100. Ratté, S.; Zhu, Y.; Lee, K.Y.; Prescott, S.A. Criticality and degeneracy in injury-induced changes in primary afferent excitability and the implications for neuropathic pain. Elife 2014, 1, e02370.
101. Geschwind, D.H. Autism: Many genes, common pathways? Cell 2008, 135, 391-395.
102. Edelman, G.M. The Remembered Present: A Biological Theory of Consciousness; Basic Books: New York, 1989.
103. Beall, C.M. Two routes to functional adaptation: Tibetan and Andean high-altitude natives. Proc Natl Acad Sci USA 2007, 104, 8655-8660.
104. Bigham, A.; Bauchet . M.; Pinto, D.; Mao, X.; Akey, J.M.; Mei, R.; Scherer, S.W.; Julian, C.G.; Wilson, M.J.; López Herráez, D.; Brutsaert, T.; Parra, E.J.; Moore, L.G.; Shriver, M.D. Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data. PLoS Genet 2010, 6, e1001116.
105. Beall, C.M. Adaptations to altitude: A current assessment. Ann Rev Anthropol 2001, 30, 423-446.
106. Beall, C.M.; Laskowski, D.; Strohl, K.P.; Soria, R.; Villena, M.; Vargas, E.; Alarcon, A.M.; Gonzales, C.; Erzurum, S.C. Pulmonary nitric oxide in mountain dwellers. Nature 2001, 414, 411-412.
107. Adriaens, P.R.; De Block, A. Why we essentialize mental disorders. J Med Philos 2013, 38, 107-127.
108. Espinoza, M.A.; Sculpher, M.J.; Manca, A.; Basu, A. Analysing heterogeneity to support decision making. In: Encyclopedia of Health Economics; Culyer, A.J. Ed. Elsevier: San Diego, US, 2014; pp 71-76.
109. Gould, S.J. Full House: The Spread of Excellence from Plato to Darwin; Harmony Books: New York, 1996.
110. Cole, D.M.; Smith, S.M.; Beckmann, C.F. Advances and pitfalls in the analysis and interpretation of resting-state FMRI data. Front Syst Neurosci 2010, 4, 1-15.
111. Chatterjee, A. A madness to the methods in cognitive neuroscience? J Cogn Neurosci 2005, 17, 847-849.
112. Danckert, J.; Mirsattarri, S.M. Neuroimaging of single cases: Benefits and pitfalls. In: Neuroimaging: Cognitive and Clinical Neuroscience; Bright, P. Ed.; Intech: Rijeka, Croatia, 2012; pp 47-68.
113. Smith, A.M.; Messier, C. Voluntary out-of-body experience: An fMRI study. Front Human Neurosci 2014, 8, 1-10.
114. Han, S.; Northoff, G.; Vogeley, K.; Wexler, B.E.; Kitayama, S.; Varnum, M.E. A cultural neuroscience approach to the biosocial nature of the human brain. Annu Rev Psychol 2013, 64, 335-359.
115. Chiao, J.Y.; Cheon, B.K.; Pornpattananangkul, N.; Mrazek, A.J. Blizinsky, K.D. Cultural neuroscience: Progress and promise. Psychol Inq 2013, 24, 1-19.
116. Kitayama, S.; Park, J. Cultural neuroscience of the self: Understanding the social grounding of the brain. Soc Cogn Affect Neurosci 2010, 5, 111-129.
117. Chiao, J.Y.; Hariri, A.R.; Harada, T.; Mano, Y.; Sadato, N.; Parrish, T.B.; Iidaka, T. Theory and methods in cultural neuroscience. Soc Cogn Affect Neurosci 2010, 5, 356-361.
118. Han, S.; Northoff, G. Understanding the self: A cultural neuroscience approach. Prog Brain Res 2009, 178, 203-212.
119. Vogeley, K.; Roepstorff, A. Contextualising culture and social cognition. Trends Cogn Sci 2009, 13, 511-516.
120. Choudhury, S.; Kirmayer, L.J.; Cultural neuroscience and psychopathology: Prospects for cultural psychiatry. Prog Brain Res 2009, 178, 263-283.
121. Domínguez, DJF; Turner, R.; Lewis, E.D.; Egan, G. Neuroanthropology: A humanistic science for the study of the culture-brain nexus. Soc Cogn Affect Neurosci 2010, 5, 138-147.
122. Campbell, B.C.; Garcia, J.R. Neuroanthropology: Evolution and emotional embodiment. Front Evol Neurosci 2009, 1, 1-6.
123. Dias, A.M. The foundations of neuroanthropology. Front Evol Neurosci 2010, 2, 1-2.
124. Domínguez D, JF; Lewis, E.D.; Turner, R.; Egan, G.F. The brain in culture and culture in the brain: A review of core issues in neuroanthropology. Prog Brain Res 2009, 178, 43-64.
125. Downey, G. 'Practice without theory': A neuroanthropological perspective on embodied learning. J Anthropol Inst 2010, 16, S22-S40.
126. Lende, D. H. Downey, G. Eds. The Encultured Brain an Introduction to Neuroanthropology; MIT Press: Cambridge MA, 2012.
127. Domínguez D, JF; Neuroanthropology and the dialectical imperative. Anthropol Theory 2012, 12, 5-27.
128. Immordino-Yang, M.H. Studying the effects of culture by integrating neuroscientific with ethnographic approaches. Psychol Inq 2013, 24, 42-46.
129. Arns, M. EEG-based personalized medicine in ADHD: Individual alpha peak frequency as an endophenotype associated with nonresponse. J Neurother 2012, 16, 123-141.
130. Gordon, E. Integrating genomics and neuromarkers for the era of brain-related personalized medicine. Personal Med 2007, 4, 201-215.
131. Gordon, E.; Liddell, B.J.; Brown, K.J.; Bryant, R.; Clark, C.R.; Das, P.; Dobson-Stone, C.; Falconer, E.; Felmingham, K.; Flynn, G.; Gatt, J.M.; Harris, A.; Hermens, D.F.; Hopkinson, P.J.; Kemp, A.H.; Kuan, S.A.; Lazzaro, I.; Moyle, J.; Paul, R.H.; Rennie, C.J.; Schofield, P.; Whitford, T.; Williams, L.M. Integrating objective gene-brain-behavior markers of psychiatric disorders. J Integr Neurosci 2007, 6, 1-34.
132. Cuijpers, P. Reynolds, C.F.; Donker, T.; Li, J.; Andersson, G.; Beekman, A. Personalized treatment of adult depression: Medication, psychotherapy, or both? A systematic review. Depress Anxiety 2012, 29, 855-864.
133. Taylor, P. Distributed agency within intersecting ecological, social and scientific processes. In: Cycles of Contingency: Developmental Systems and Evolution; Oyama, S.; Griffiths, P. E.; Gray, R. D., Eds.; MIT Press: Cambridge, MA, 2001; pp 313-332.
134. Thamrin, C.; Zindel, J.; Nydegger, R.; Reddepatrick, S.; Watt, R.A.; Suki, B.; Frey, U. Predicting future risk of asthma exacerbations using individual conditional probabilities. J Allergy Clin Immunol 2011, 127, 1494-1502.
135. Frey, U.; Maksyum, G.; Suki, B. Temporal complexity in clinical manifestations of lung disease. J Appl Physiol 2011, 110, 1723-1731.
136. Frey, U.; Suki, B. 2008. Complexity of chronic asthma and chronic obstructive pulmonary disease: Implications for risk assessment, and disease progression and control. Lancet 2008, 372, 1088-1099.
137. Chung, K.F. New treatments for severe treatment-resistant asthma: Targeting the right patient. Lancet Respir Med 2013, 8, 639-652.
138. McDonald, V.M.; Higgins, I.; Wood, L.G.; Gibson, P.G. Multidimensional assessment and tailored interventions for COPD: Respiratory utopia or common sense? Thorax 2013, 68, 691-694.
139. Gibson, P.G.; McDonald, V.M.; Marks, G.B. Asthma in older adults. Lancet 2010, 376, 803-813.
140. Chen, R.; Snyder, M. Systems biology: Personalized medicine for the future? Curr Opin Pharmacol 2012, 12, 623-628.
141. Gray, J.A.M. The shift to personalised and population medicine. Lancet 2013, 382, 200-201.
142. Hamburg, M.A. The path to personalized medicine. N Engl J Med 2010, 363, 301-304.
143. Harvey, A.; Brand, A.; Holgate, S.T.; Kristiansen, L.V.; Lehrach, H.; Palotie, A.; Prainsack, B. The future of technologies for personalised medicine. N Biotechnol 2012, 29, 625-33.
144. Tremblay J.; Hamet, P. Role of genomics on the path to personalized medicine. Metabolism 2013, 62, S2-S5.
145. West, B.J. Where Medicine Went Wrong: Rediscovering the Path to Complexity, Studies of Nonlinear Phenomena in Life Science, Vol. 11; World Scientific: Teaneck, NJ, 2006.
146. McInerney, J.D.; Edelman, E.; Nissen, T.; Reed, K.; Scott, J.A. Preparing health professionals for individualized medicine. Personal Med 2012, 9, 529-537.
147. Snyderman, R. Personalized health care: From theory to practice. Biotechnol J 2012, 7, 973-979.
148. Golubnitschaja, O. Neurodegeneration: Accelerated ageing or inadequate healthcare? EPMA J 2010, 1, 211-215.
149. Grunstein, R. Personalized medicine in sleep health. In: Integrative Neuroscience and Personalized Medicine; Gordon, E.; Koslow, S. Eds.; Oxford University Press: New York, NY, 2010; pp 181-204.
150. Hui-Leng, T.; Kheirandish-Gozal, L.; Gozal, D. The promise of translational and personalised approaches for paediatric obstructive sleep apnoea: An 'Omics' perspective. Thorax 2014. Doi: 10.1136/thoraxjnl-2013-204640.
151. Plenge, R.M.; Bridges, S.L. Personalized medicine in rheumatoid arthritis: Miles to go before we sleep. Arthritis Rheum 2001, 63, 590-593.
152. Baltogiannis, G.; Katsios, C.S; Roukos, D.H. Targeting the individual cancer patient. In: Advances in Personalized Cancer Management; Roukos, D. H. Eds.; Future Medicine: London, UK, 2011; pp 8-28.
153. Hricak, H. Oncologic imaging: A guiding hand of personalized cancer care. Radiology 2011, 259, 633-640.
154. Heinemann, V.; Douillard, J.Y.; Ducreux, M.; Peeters, M. Targeted therapy in metastatic colorectal cancer-An example of personalised medicine in action. Cancer Treat Rev 2013, 39, 592-601.
155. Doz, F.; Marvanne, P.; Fagot-Largeault, A. The person in personalised medicine. Eur J Cancer 2013, 49, 1159-1160.
156. Miller, F.A.; Hayeems, R.Z.; Bytautas, J.P.; Bedard, P.L.; Ernst, S.; Hirte, H.; Hotte, S.; Oza, A.; Razak, A.; Welch, S.; Winquist, E.; Dancey, J.; Siu, L. L. Testing personalized medicine: Patient and physician expectations of next-generation genomic sequencing in late-stage cancer care. Eur J Human Genet 2014, 22, 391-395.
157. Stricker, T. Catenacci, D.V.T, Seiwert, T.Y. Molecular profiling of cancer-The future of personalized cancer medicine: A primer on cancer biology and the tools necessary to bring molecular testing to the clinic. Semin Oncol 2011, 38, 173-185.
158. Coleman, W.B. Breast cancer personalized medicine. Am J Pathol 2013, 183, 1036-1037.
159. Zolotov, S.; Yosef, D.B.; Rishe, N.D.; Yesha, Y.; Karnieli, E. Metabolic profiling in personalized medicine: Bridging the gap between knowledge and clinical practice in Type 2 diabetes. Personal Med 2011, 8, 445-456.
160. Grant, R.W.; Wexler, D.J. Personalized medicine in Type 2 diabetes: What does the future hold? Diabetes Manage 2012, 2, 199-204.
161. Mobasheri, A.; Cassidy, J.P. Biomarkers in veterinary medicine: Towards targeted, individualised therapies for companion animals. Vet J 2010, 185, 1-3.
162. Davids, K.; Araújo, D. The concept of 'Organismic Asymmetry' in sport science. J Sci Med Sport 2010, 13, 633-640.
163. Savard, J. Personalised medicine: A critique on the future of health care. J Bioeth Inq 2013, 10, 197-203.
164. Rowe, T. Coevolution of the mammalian middle ear and neocortex. Science 1996, 273, 651-654.
165. Budd, G.E. On the origin and evolution of major morphological characters. Biol Rev 2006, 81, 609-628.
166. Luo, Z.; Chen, P.; Li, G.; Chen, M. A new eutriconodont mammal and evolutionary development in early mammals. Nature 2007, 446, 288-293.
167. Meng, J.; Wang, Y.; Li, C. Transitional mammalian middle ear from a new Cretaceous Jehol eutriconodont. Nature 2011, 472, 181-185.
168. Scheper-Hughes, N.; Lock, M.M. The mindful body: A prolegomenon to future work in medical anthropology. Med Anthropol Q 1987, 1, 6-41.
169. Bechtel, W.P.; Richardson, R.C. Discovering Complexity: Decomposition and Localization as Strategies in Scientific Research; Princeton University Press: Princeton, NJ, 1992.
170. Bechtel, W.P. What knowledge must be in the head in order to acquire language? In: Communicating Meaning: The Evolution and Development of Language; Velichkovsky, B.; Rumbaugh, D. M., Eds.; Lawrence Erlbaum Associates: Hillsdale, NJ, 1996; pp 45-78.
171. Bourdette D.; Naismith R.T. BCG vaccine for clinically isolated syndrome and MS: Infections and protective immunity. Neurology 2014, 82, 15-16.
172. Fernandez-Leon, J.A. Robustness as a non-localizable relational phenomenon. Biol Rev 2013. Doi: 10.1111/brv.12067.